Jiangsu Gdk Biological Technology Future Growth

Future criteria checks 3/6

Jiangsu Gdk Biological Technology is forecast to grow earnings at 102.4% per annum. EPS is expected to grow by 102.4% per annum.

Key information

102.4%

Earnings growth rate

102.4%

EPS growth rate

Biotechs earnings growth	33.0%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	Low
Last updated	19 Apr 2024

Recent future growth updates

No updates

Recent updates

Optimistic Investors Push Jiangsu Gdk Biological Technology Co., Ltd (SHSE:688670) Shares Up 25% But Growth Is Lacking

Mar 08

Earnings and Revenue Growth Forecasts

SHSE:688670 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2024	33	-129	-26	29	N/A
12/31/2023	135	-71	27	81	N/A
9/30/2023	219	-25	46	76	N/A
6/30/2023	429	94	17	75	N/A
3/31/2023	412	81	-68	39	N/A
12/31/2022	318	42	-130	39	N/A
9/30/2022	264	38	-242	103	N/A
6/30/2022	377	89	-309	58	N/A
3/31/2022	375	85	-308	73	N/A
12/31/2021	392	82	-282	104	N/A
9/30/2021	676	207	-121	101	N/A
6/30/2021	534	138	-11	166	N/A
3/31/2021	578	146	32	150	N/A
12/31/2020	589	155	69	109	N/A
12/31/2019	67	-19	-75	-54	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688670 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).

Earnings vs Market: 688670 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 688670 is expected to become profitable in the next 3 years.

Revenue vs Market: Insufficient data to determine if 688670's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 688670's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 688670's Return on Equity is forecast to be high in 3 years time

Jiangsu Gdk Biological Technology Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Recent updates

First quarter 2024 earnings released: CN¥0.17 loss per share (vs CN¥0.29 profit in 1Q 2023)

Jiangsu Gdk Biological Technology Co., Ltd, Annual General Meeting, May 08, 2024

Jiangsu Gdk Biological Technology Co., Ltd to Report Q1, 2024 Results on Apr 16, 2024

Optimistic Investors Push Jiangsu Gdk Biological Technology Co., Ltd (SHSE:688670) Shares Up 25% But Growth Is Lacking

Less than half of directors are independent

New minor risk - Share price stability

Third quarter 2023 earnings released: CN¥0.39 loss per share (vs CN¥0.56 profit in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.01 loss per share (vs CN¥0.12 loss in 2Q 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Jiangsu gdk Biotechnology Co., Ltd. to Report First Half, 2023 Results on Aug 03, 2023

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.03 loss in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.48 (vs CN¥1.10 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.79 (vs CN¥1.55 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies